Adjuvant chemotherapy and radiation therapy for elimination of residual microscopic non-small cell lung cancer.
- S E Wright
- V R Sicola
- H Martinez
- E Thompson
- D Pratt
Affiliations: Medical Service, Veterans Affairs Medical Center-111, Amarillo, TX 79106, USA.
- Published online on: February 1, 1999 https://doi.org/10.3892/ijo.14.2.347
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
This study determined if patients with residual microscopic non-small cell lung cancer (NSCLC) following lung resection treated with combination chemotherapy and radiation realize prolonged survival. Ten men with microscopic NSCLC following resection were given chemotherapy and radiation therapy. Four (40%) of the ten patients were disease-free at 45 months and fully functional. Only two (20%) of the patients died of recurrent lung cancer. Of patients who died of lung cancer, recurrence occurred within five months of treatment and death occurred within one year. The findings suggest combination chemotherapy and radiation therapy delay or prevent recurrence from residual microscopic NSCLC following lung resection.